Gemphire Therapeutics Inc (GEMP) is traded on BATS Exchange in USA. It is located in MICHIGAN, U.S.A and employs 17 people. Gemphire Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap
' category with current market capitalization of 95.74 M. Gemphire Therapeutics Inc has 13.78 M outstanding shares of which 577.3 K shares are currently shorted by private and institutional investors with about 16.0 trading days to cover.
Gemphire Therapeutics Inc. currently holds about 25.34 M in cash with (23.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.38.
Check Gemphire Therapeutics Probability Of Bankruptcy